MBP metabolic pharmaceuticals limited

chances of success, page-6

  1. 47 Posts.
    Ed,
    wow, you believe that a company would go through the whole process of repeating the phase 2 trials knowing they had a product that had no chance of success? Waste good money that could be spent on developing and researching their other products? Put all the reputations of the management and research team on the line for something that was a dud?
    Think again!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.